// App-Quantinova.ai

OC 15.5 : Validating Direct Oral Anticoagulants (DOAC) for Use in Children by the Throm-PED DOAC Registry of the International Pediatric Thrombosis Network

Researchers

Presenter

  • S. Holzhauer

Principal Investigators

  • P. Monagle

  • C. Male

  • R. Bhat

  • M. Bordbar

  • R. Natesirinilkul

  • S. Saini

  • M. Simpson

  • C. van Ommen

  • L. Raffini

Medical Centers

  • University Medicine, Charite, Berlin, Germany, Berlin, Berlin, Germany

  • Dept of Paediatrics, Univ of Melbourne, and Royal Children's Hospital, Melbourne, Victoria, Australia

  • Medical University of Vienna, Vienna, Austria, Vienna, Wien, Austria

  • Rush University Medical Center, Chicago, Illinois, United States

  • Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz, Iran

  • Faculty of Medicine Chiang Mai University, Chiang Mai, Thailand, Chiang Mai, Chiang Mai, Thailand

  • St. Louis Children's Hospital-Washington Universit, St Luis, Missouri, United States

  • Rush University Medical Center, Chicago, Illinois, United States

  • Erasmus Medical Center-Sophia Children’s, Rotterdam, The Netherlands, Rotterdam, Zuid-Holland, Netherlands

  • The Childrenaaas Hospital of Philadelphia, Philadelphia, Pennsylvania, United States

Locations

  • Germany

  • Australia

  • Austria

  • United States

  • Iran

  • Thailand

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Pradax

Outcome

  • N/A

Study Design

  • Observational

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved